CIK 0001590750
- Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471187261
- Phone
- +1 617-272-4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Business Officer bought 200 shares at $7.55 ($1,510)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 778 shares (grant or award)
- 4 Open-market sale Director sold 5,800 shares at an average $14.34 ($83,190)
- 4 Open-market sale Director sold 15,000 shares at an average $15.40 ($230,977)
- 4 Open-market sale Director sold 10,258 shares at an average $13.89 ($142,519)
- 4 Open-market sale Director sold 5,902 shares at an average $14.14 ($83,452)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 279,067 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 11 of 14 · 264 filings